美国康涅狄格大学免疫学、干细胞和癌症研究博士后职位招聘

Postdoctoral and Visiting Scholar positions in Immunology, Stem Cells, and Cancer

· University of Connecticut

· Location: Storrs, CT

· Job Number: 7062916

· Posting Date: Jan 6, 2020

Job Description

The University of Connecticut is one of the top public research universities in USA. Visiting Scholar or The University of Connecticut is one of the top public research universities in USA. Postdoctoral and Visiting Scholar positions are available in Dr. Laijun Lai’s laboratory. The research projects include: 1) enhancing antitumor immunity by recombinant proteins or antibodies (Am J Cancer Res. 7:1714-1723, 2017; Molecular Cancer Therapeutics, 15(10):2413-2421, 2016; Cancer Research. 71:61-67, 2011; 2) preventing and treating autoimmune diseases by proteins, embryonic stem cells or induced pluripotent stem cells (iPSCs)-derived cells (Stem cells. 27:3012, 2009; Blood. 118:3410, 2011; Journal of Clinical Investigation. 122:3552, 2012; Stem cells and Development. 23:1491-500, 2014; Scientific Reports. 5: 9882, 2015; J Autoimmun. 58:36-47, 2015; Br J Haematol. 175:505-516, 2016; Stem Cells Transl Med. 6:121-130, 2017; Cell Immunol. 322:84-91, 2017; Frontiers in Immunology.9:2657, 2018; J Immunol. 203:400-407, 2019; Stem Cell Res Ther. 10:239, 2019; Adv Healthc Mater. 8(9):e1800987, 2019); and 3) improving T cell regeneration after bone marrow transplantation (Journal of Immunology, 186: 1915, 2011; Transplantation. 92:516, 2011; Plos ONE 8(12): e82998, 2013; Immunology. 144:245-253, 2015; Cell Immunol. 335:22-29, 2019). Candidates should have PhD, MD/PhD, or MD. A strong background in Cellular & Molecular Biology and previous research experience or training in immunology, stem cells, or cancer, and mouse models is preferred. If interested, please send your cover letter and CV to: laijun.lai@uconn.edupositions are available in Dr. Laijun Lai’s laboratory. The research projects include: 1) enhancing antitumor immunity by recombinant proteins or antibodies (Am J Cancer Res. 7:1714-1723, 2017; Molecular Cancer Therapeutics, 15(10):2413-2421, 2016; Cancer Research. 71:61-67, 2011; 2) preventing and treating autoimmune diseases by proteins, embryonic stem cells or induced pluripotent stem cells (iPSCs)-derived cells (Stem cells. 27:3012, 2009; Blood. 118:3410, 2011; Journal of Clinical Investigation. 122:3552, 2012; Stem cells and Development. 23:1491-500, 2014; Scientific Reports. 5: 9882, 2015; J Autoimmun. 58:36-47, 2015; Br J Haematol. 175:505-516, 2016; Stem Cells Transl Med. 6:121-130, 2017; Cell Immunol. 322:84-91, 2017; Frontiers in Immunology.9:2657, 2018; J Immunol. 203:400-407, 2019; Stem Cell Res Ther. 10:239, 2019; Adv Healthc Mater. 8(9):e1800987, 2019); and 3) improving T cell regeneration after bone marrow transplantation (Journal of Immunology, 186: 1915, 2011; Transplantation. 92:516, 2011; Plos ONE 8(12): e82998, 2013; Immunology. 144:245-253, 2015; Cell Immunol. 335:22-29, 2019). Candidates should have PhD, MD/PhD, or MD. A strong background in Cellular & Molecular Biology and previous research experience or training in immunology, stem cells, or cancer, and mouse models is preferred. If interested, please send your cover letter and CV to: laijun.lai@uconn.edu